Latest Market Access News

Aumake Limited has launched Bio-Basic Ergothioneine, marking the debut of its innovative capital-light incubation model aimed at scaling premium health brands with minimal upfront investment.

Aurum Resources Limited has had its trading suspension lifted immediately following the lodgement of its annual financial report, allowing its shares to resume trading on the ASX.

Xstate Resources reports steady progress on its Diona-1 well in Queensland, confirming its majority ownership of ATP 2077 and targeting multiple proven gas reservoirs with promising potential.

NexGen Energy has launched a dual equity offering, raising approximately C$400 million in North America and AUD 400 million in Australia to advance its flagship Rook I uranium project and support corporate growth.

BPH Global Ltd will lift its trading suspension on 2 October 2025 following the lodgement of its annual financial report for the year ended 30 June 2025.

Flynn Gold Limited’s FG1OA securities have been suspended from trading due to non-compliance with ASX listing rules, raising questions about the company’s regulatory standing.

The ASX has suspended the securities of over 20 companies for failing to lodge their periodic reports on time, signaling regulatory vigilance and raising questions about compliance and market impact.

Altech Batteries has partnered with AMPower to immediately market and distribute sodium nickel chloride batteries across Europe, Australia, and the USA, fast-tracking revenue ahead of its large-scale CERENERGY project in Germany.

Hydrix Limited delays its FY25 financial statements due to a pending independent valuation of its Wavewise Analytics shareholding, triggering an automatic trading suspension from 1 October 2025.

Nova Eye Medical has gained regulatory approval for its iTrack Advance glaucoma device in China, setting the stage for significant market expansion and sales growth from late fiscal 2026.

CurveBeam AI Limited has secured A$6.5 million in new capital to fuel global growth of its HiRise™ weight-bearing CT scanner, deepen its partnership with orthopaedic giant Stryker, and advance a potential strategic deal in China.

CurveBeam AI has secured A$6.5 million through an institutional placement and completed a €10 million vendor financing facility to accelerate sales of its HiRise™ CT scanner. The company is also progressing a strategic partnership in China and advancing surgical robot validation.